XWELL, Inc. (NAS: XWEL) Stock Analysis & Fundamentals | ScreenerHero

Create free account

XWELXWELL, Inc.

NAS · US · Healthcare · Diagnostics & Research · xwell.com

1.050USD-2.78%Mkt Cap: 8.87M $P/E: —1d ago

XWELL, Inc. engages in the provision of health and wellness services to travelers in the United States and internationally. It operates in three segments: XpresSpa, XpresTest, and Naples Wax Center. The XpresSpa segment …

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$201.86BUSDP/E 29.8

Danaher Corporation

$145.10BUSDP/E 39.7

$45.85BUSDP/E 44.2

IDEXX Laboratories, Inc.

$45.44BUSDP/E 42.4

Agilent Technologies, Inc.

$38.44BUSDP/E 27.3

Waters Corporation

$37.13BUSDP/E 48.1

IQVIA Holdings Inc.

$35.13BUSDP/E 26.2

$28.78BUSDP/E 34.6

Mettler-Toledo International Inc.

$26.98BUSDP/E 31.4

Quest Diagnostics Incorporated

$23.18BUSDP/E 23.1

Labcorp Holdings Inc.

$23.12BUSDP/E 25.0

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.36BUSDP/E 33.9

Eurofins Scientific SE

$13.06BUSDP/E 27.3

$12.46BUSDP/E 53.7

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.26BUSDP/E 21.6

BillionToOne, Inc.

$5.90BUSDP/E 237.4

Twist Bioscience Corporation

Sotera Health Company

$5.21BUSDP/E 44.6

$4.73BUSDP/E 54.8

DiaSorin S.p.A.

$3.75BUSDP/E 26.5

Adaptive Biotechnologies Corporation

NeoGenomics, Inc.

GeneDx Holdings Corp.

Vimian Group AB (publ)

$1.64BUSDP/E 41.7

Personalis, Inc.

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Clínica Baviera, S.A.

$1.02BUSDP/E 21.4

OPKO Health, Inc.

Castle Biosciences, Inc.

$616.40MUSDP/E 40.2

Myriad Genetics, Inc.

Fulgent Genetics, Inc.

$293.12MUSDP/E 2.9

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

Proteome Sciences plc

ENDRA Life Sciences Inc.

Oxford BioDynamics Plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Leveljump Healthcare Corp.

Prostatype Genomics AB (publ)

Telo Genomics Corp.

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap8.87M $

Enterprise Value10.06M $

Revenue (TTM)28.82M $

Gross Profit7.51M $

Net Income (TTM)-16.99M $

Revenue/Share4.730 USD

Last Price1.050 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees175

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-0.40

PEG—

EV/EBITDA-0.94

EV/Revenue0.35

P/S0.31

P/B-0.96

EPS (TTM)-5.59

EPS (Forward)-2.63

52W Range

0.260041% of range2.200

52W High2.200 USD

52W Low0.2600 USD

Profitability

Gross Margin25.70%

Oper. Margin-81.56%

EBITDA Margin-37.27%

Profit Margin-58.17%

ROE77.10%

ROA-151.48%

Growth

Revenue Growth-5.50%

Earnings Growth—

Cash Flow & Leverage

Operating CF-8.71M $

CapEx (TTM)2.96M $

FCF Margin-20.15%

FCF Yield-65.51%

Net Debt-8.49M $

Net Debt/EBITDA0.79

Balance Sheet

Debt/Equity-0.57

Current Ratio2.35

Quick Ratio2.16

Book Value/Sh-1.0980 USD

Cash/Share1.990 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateJun 11, 2020

Splits

Last Split1:20

Split DateSep 28, 2023

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.8.44M

Float6.37M

Insiders18.48%

Institutions14.76%

Short Interest

Short Ratio2.3d

Short % Float3.76%

Short % Out.3.24%

Shares Short273.71K

Short (prev mo.)402.50K

Technical

SMA 501.223 (-14.2%)

SMA 2000.9627 (+9.1%)

Beta1.03

S&P 52W Chg20.25%

Avg Vol (30d)196.89K

Avg Vol (10d)384.66K

Technical Indicators

RSI (14)46.1

MACD-0.0610

MACD Signal-0.0679

MACD Hist.+0.0069

BB Upper1.239 USD

BB Middle1.065 USD

BB Lower0.8908 USD

BB Width32.71%

ATR (14)0.1052 USD

Vol Ratio (20d)0.37x